319 related articles for article (PubMed ID: 15167512)
1. Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience.
Pelizzo MR; Boschin IM; Toniato A; Pagetta C; Piotto A; Bernante P; Casara D; Pennelli G; Rubello D
Nucl Med Commun; 2004 Jun; 25(6):547-52. PubMed ID: 15167512
[TBL] [Abstract][Full Text] [Related]
2. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
3. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
4. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.
Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654
[TBL] [Abstract][Full Text] [Related]
5. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
[TBL] [Abstract][Full Text] [Related]
6. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
[TBL] [Abstract][Full Text] [Related]
7. Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.
Lombardi CP; Bellantone R; De Crea C; Paladino NC; Fadda G; Salvatori M; Raffaelli M
World J Surg; 2010 Jun; 34(6):1214-21. PubMed ID: 20052467
[TBL] [Abstract][Full Text] [Related]
8. Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated?
Dobrinja C; Pastoricchio M; Troian M; Da Canal F; Bernardi S; Fabris B; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S34-S39. PubMed ID: 28506411
[TBL] [Abstract][Full Text] [Related]
9. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
Khan M; Syed AA; Khan AI; Hussain SR; Urooj N
Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398
[TBL] [Abstract][Full Text] [Related]
10. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients.
Pelizzo MR; Boschin IM; Toniato A; Piotto A; Bernante P; Pagetta C; Rampin L; Rubello D
Eur J Surg Oncol; 2006 Dec; 32(10):1144-8. PubMed ID: 16872798
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
12. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
McHenry C; Jarosz H; Lawrence AM; Paloyan E
Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
[TBL] [Abstract][Full Text] [Related]
13. Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting.
Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Kim TY; Han M; Song DE; Sung TY; Yoon JH; Hong SJ; Ryu JS; Shong YK; Kim WB
Ann Surg Oncol; 2017 Sep; 24(9):2596-2602. PubMed ID: 28600731
[TBL] [Abstract][Full Text] [Related]
14. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
[TBL] [Abstract][Full Text] [Related]
15. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
[TBL] [Abstract][Full Text] [Related]
17. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
18. [Clinical picture of differentiated thyroid carcinoma in the T1 stage].
Czarniecka A; Włoch J; Lange D
Wiad Lek; 2001; 54 Suppl 1():225-33. PubMed ID: 12182030
[TBL] [Abstract][Full Text] [Related]
19. Locally advanced differentiated thyroid carcinoma: a 35-year mono-institutional experience in 280 patients.
Rosa Pelizzo M; Toniato A; Boschin IM; Piotto A; Bernante P; Pagetta C; Palazzi M; Maria Guolo A; Preo P; Nibale O; Rubello D
Nucl Med Commun; 2005 Nov; 26(11):965-8. PubMed ID: 16208173
[TBL] [Abstract][Full Text] [Related]
20. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
